| Serial Number | 97786978 |
| Word Mark | TESORAI |
| Filing Date | Wednesday, February 8, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 16, 2024 |
| Goods and Services | Downloadable mobile application software, downloadable computer software, and recorded computer software featuring technology that allows users to analyze mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Downloadable mobile application software, downloadable computer software, and recorded computer software for research services to support pharmaceutical and biotech research and drug development; Downloadable mobile application software, downloadable computer software, and recorded computer software for data analytics, data preprocessing, data filtering and ranking, all of which in the fields of pharmaceutical and biotech research and drug development; Downloadable mobile application software, downloadable computer software, and recorded computer software featuring technology that allows users to to view, manipulate, and analyze data, information and reports in the fields of pharmaceutical and biotech research and drug development |
| Goods and Services | Pharmaceutical and medical therapeutics for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders, namely, infectious disease, women's health disorders, mental health disorders; Pharmaceutical and medical preparations for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders, namely, infectious disease, women's health disorders, mental health disorders |
| Goods and Services | Scientific and technological services as well as research and design services relating thereto, namely, research services to support pharmaceutical and biotech research and clinical development; Industrial analysis and research services, namely, mass spectrometry services and life sciences research services; Scientific research; Preclinical development of therapeutic products; Design and development of software; Laboratory testing; Chemical and biological laboratory services; Consultancy relating to laboratory testing; Data analytics services in the life sciences industry, namely, raw data preprocessing via artificial intelligence-enabled pipelines that preprocess mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Data filtering and ranking services in the life sciences industry, namely, the development of algorithms to optimize ranking of interactions and hits from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of computational models in the life sciences industry that predict interactions from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of analytical approaches to generate novel biology and disease insights both from models and data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for research services to support pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for data analytics, data preprocessing, data filtering and ranking, all of which in the fields of pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software that allows users to view, manipulate, and analyze data, information and reports in the fields of pharmaceutical and biotech research and drug development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | Del Mar, CA 92014 |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Del Mar, CA 92014 |
| Event Date | Event Description |
| Saturday, February 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, February 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 6, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 14, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 14, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 2, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, April 24, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, April 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 29, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, April 29, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 26, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 10, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |